Anthera Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income.
Profit Margin
| 2012 | 0 | -59.39M | |
|---|---|---|---|
| 2013 | 0 | -33.10M | |
| 2014 | 0 | -30.30M | |
| 2015 | 3.18M | -34.91M | -1096.14% |
| 2016 | 145K | -53.60M | -36967.59% |
| 2017 | 0 | -16.93M | |
| 2019 | 0 | 0 | |
| 2020 | 0 | 0 | |
| 2021 | 0 | 0 | |
| 2022 | 0 | 0 |
ANTH Income Statement (2012 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 145K | 3.18M | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 281K | 46.25K | 30.86K | 21.83K | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | -281K | 98.74K | 3.15M | -21.83K | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 0 | 0 | 0 | 0 | 28.59M | 46.25M | 30.86M | 21.83M | 21.68M | 49.21M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 0 | 0 | 0 | 0 | 36.53M | 57.32M | 38.42M | 28.45M | 28.24M | 55.93M |
Operating income | 0 | 0 | 0 | 0 | -36.43M | -57.17M | -35.24M | -28.45M | -28.24M | -55.93M |
Other income (expenses), net | 0 | 0 | 0 | 0 | 9.55M | 1.65M | 23K | -1.14M | -2.61M | -3.46M |
Income before tax | 0 | 0 | 0 | 0 | -26.87M | -55.52M | -35.22M | -29.60M | -30.86M | -59.39M |
Income tax expense | 0 | 0 | 0 | 0 | -9.93M | -1.92M | -308K | 705K | 2.24M | 0 |
Net income | 0 | 0 | 0 | 0 | -16.93M | -53.60M | -34.91M | -30.30M | -33.10M | -59.39M |
Earnings per share | ||||||||||
Basic EPS | 0 | 0 | 0 | 0 | -1.65 | -10.38 | -7.84 | -11.13 | -14.5 | -65.92 |
Diluted EPS | 0 | 0 | 0 | 0 | -1.65 | -10.38 | -7.84 | -11.13 | -14.5 | -65.92 |